SCHEMBL6254524

SCHEMBL6254524

CC(C)CCN(C(=O)c1ccc(-c2cc(C(=O)O)ccc2Cl)cc1)C(=O)N(C)C#N

nearest known ligand 0.38

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
SRD5A2 P31213 2/20 0.38
RARB P10826 1/20 0.34
RORC P51449 3/20 0.34
NR1H4 Q96RI1 1/20 0.34
PRSS12 P56730 1/20 0.34
XDH P47989 1/20 0.33
KDM4E B2RXH2 1/20 0.33
TSHR P16473 1/20 0.33
KMT2A Q03164 1/20 0.32
SMN1; SMN2 Q16637 1/20 0.32
GRIN2D O15399 1/20 0.32
GRIN2A Q12879 1/20 0.32
GRIN2B Q13224 1/20 0.32
GRIN2C Q14957 1/20 0.32
LPAR1 Q92633 1/20 0.32
LPAR5 Q9H1C0 1/20 0.32
AURKA O14965 1/20 0.32
TPX2 Q9ULW0 1/20 0.32
MAPK14 Q16539 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6252192 0.92 SRD5A2 (0.47) SRD5A2RARBNR1H4PRSS12XDH
SCHEMBL6251533 0.89 SRD5A2 (0.37) SRD5A2RORCTSHRKMT2A
SCHEMBL6251138 0.89 GRIK1 (0.38) RARBXDHGRIN2DGRIN2AGRIN2B
SCHEMBL6251554 0.85 LDHA (0.38) SRD5A2PRSS12XDHKDM4EMAPK14
SCHEMBL6255637 0.80 LPAR1 (0.31) XDHKDM4EKMT2ALPAR1LPAR5
SCHEMBL7452320 0.77 F2 (0.35) RORC
SCHEMBL6252227 0.76 PIK3CD (0.36) NR1H4TSHRKMT2ASMN1; SMN2
SCHEMBL7447953 0.75 NAMPT (0.43) KMT2ASMN1; SMN2LPAR1LPAR5
SCHEMBL6257637 0.74 NAMPT (0.33) LPAR1LPAR5
SCHEMBL5924969 0.74 CTSB (0.57) KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1569954-A1 CYANOMETHYL DERIVATIVES AS CYSTEINE PROTEASE INHIBITORS AXYS PHARMACEUTICALS, INC. (US) 2005-09-07 EP disclosed
WO-2004052921-A1 CYANOMETHYL DERIVATIVES AS CYSTEINE PROTEASE INHIBITORS AXYS PHARMACEUTICALS, INC. (US) 2004-06-24 WO disclosed